A new study published in the Journal of the American Medical Association shows that Fecal Microbiota Transplant capsules are just as effective as colonoscopy in treating C. difficile infections. The capsule delivery method is non-invasive, less expensive, and has no risks associated with sedation.
Researchers have used gene therapy to treat Fabry disease, a rare inherited enzyme deficiency that can damage major organs and shorten lifespan. The treatment involves transplanted altered stem cells with copies of the fully functional gene responsible for the missing enzyme.
A study has demonstrated a clear new evidence for mind-body connection in breast cancer survivors, showing that mindfulness meditation and support groups can influence telomere length. This suggests potential health benefits beyond the initial three-month period studied.
Researchers in Calgary have launched the world's first gene therapy clinical trial for Fabry disease, a rare inherited enzyme deficiency. The trial aims to transplant stem cells with a working copy of the GLA gene into patients, potentially curing the condition.
Physicians at Alberta Children's Hospital successfully completed the world's first liver cell transplant on a Canadian baby with Urea Cycle Disorder, improving ammonia levels and buying time for a potential liver transplant. The procedure was performed as part of a research trial sponsored by Cytonet LLC.